Direct-to-consumer nootropics brand optimizing for retention and social reach
Thesis sells cognitive-enhancement supplements targeting focus, stress, and memory through data-driven formulations. The hiring mix is heavily skewed toward marketing and ops (11 of 13 roles), with leadership gaps in growth and operations — a pattern consistent with their stated pain points around churn reduction, content scaling, and topline growth. Their project list (win-back campaigns, paid social, high-volume TikTok/Instagram content) confirms a customer-acquisition and retention focus, while pain points around claims substantiation and ingredient sourcing suggest regulatory and supply-chain headwinds typical of regulated supplement brands.
Notable leadership hires: Growth Head, Chief of Staff
Thesis is a New York-based nootropics company founded in 2017, operating in the wellness and cognitive-enhancement space. The product targets neurotransmitters and hormones linked to focus, learning, motivation, and stress resilience through formulated supplements. With 11–50 employees and active hiring across marketing, operations, design, and research, Thesis is scaling direct-to-consumer channels, particularly social platforms (TikTok and Instagram) where they produce high-volume content. Current operational challenges center on customer retention, content production velocity, and substantiating health claims in a regulated category.
Thesis makes nootropic supplements designed to enhance cognitive function across focus, memory, motivation, and stress resilience. Founded in 2017 in New York, they use data-driven formulations and iterative testing to target specific neurotransmitters and hormones.
Thesis relies on Meta, TikTok, Google, and Instagram for customer acquisition and engagement. Current projects include high-volume TikTok and Instagram reels, paid social strategy, win-back campaigns, and street interview content series to reach cognitive-enhancement and ADHD communities.
Other companies in the same industry, closest in size